Reports about changes in S1R density with age and disease are conflicting so far, and with the emergence of S1R as a potential therapeutic target in neurodegenerative diseases and in tumours, further elucidation of the expression, function, density and role of S1R is of highest interest. This evidence concerns the gene TMBIM4 and neoplasm.